IMPACT OF MINOR HISTOCOMPATIBILITY ANTIGEN MISMATCHES ON GRAFT-VERSUS-HOST DISEASE IN NON-MYELOABLATIVE OR REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Carniti, C. [1 ]
Spina, F. [1 ]
Farina, L. [1 ]
Raganato, A. [1 ]
Vendramin, A. [1 ]
Di Terlizzi, S. [1 ]
Dodero, A. [1 ]
Frungillo, N. [1 ]
Corradini, P. [2 ]
机构：
[1] Ist Nazl Tumori, I-20133 Milan, Italy
[2] Univ Milan, Milan, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0148
引用
收藏
页码：56 / 57
页数：2
相关论文
共 50 条
  • [41] Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies
    Mineishi, S
    Kanda, Y
    Saito, T
    Nakai, K
    Makimoto, A
    Kami, M
    Tanosaki, R
    Wakasugi, H
    Tobinai, K
    Takaue, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 296 - 303
  • [42] Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation
    Mielcarek, M
    Burroughs, L
    Leisenring, W
    Diaconescu, R
    Martin, PJ
    Sandmaier, BM
    Maloney, DG
    Maris, MB
    Chauncey, TR
    Shizuru, JA
    Blume, KG
    Hegenbart, U
    Niederwieser, D
    Forman, S
    Bruno, B
    Woolfrey, A
    Storb, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (03) : 381 - 391
  • [43] Bone Marrow Graft-Versus-Host Disease in Reduced Intensity Conditioned Major Histocompatibility Complex Matched Murine Allogeneic Hematopoietic Cell Transplantation
    Silveira, Pablo
    Shahin, Kifah
    Mattar, Zamil
    Hsu, Wei Hsun
    Benda, Linda
    Hart, Derek N. J.
    Bradstock, Kenneth
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S199 - S199
  • [44] Bone Marrow Graft-Versus-Host Disease in Reduced Intensity Conditioned Major Histocompatibility Complex Matched Murine Allogeneic Hematopoietic Cell Transplantation
    Silveira, Pablo
    Shahin, Kifah
    Mattar, Zamil
    Hsu, Wei-Hsun
    Bendall, Linda
    Hart, Derek N. J.
    Bradstock, Kenneth F.
    TRANSPLANTATION, 2018, 102 : S421 - S421
  • [45] Non-Myeloablative Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia: Graft-Versus-Host Disease Potentiates Graft-Versus-Leukemia Effect and Improves Overall Survival
    Pizzola, Christopher J.
    Rakszawski, Kevin L.
    Ehmann, W. Christopher
    Rybka, Witold B.
    Wirk, Baldeep
    Naik, Seema
    Zheng, Hong
    Silar, Brook
    Mackey, Gina
    Mineishi, Shin
    Minagawa, Kentaro
    Claxton, David F.
    BLOOD, 2019, 134
  • [46] Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation
    Busca, A
    Rendine, S
    Locatelli, F
    Sizzano, F
    Dall'Omo, AM
    Rossi, G
    Falda, M
    HEMATOLOGY, 2005, 10 (01) : 1 - 10
  • [47] Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
    Abrahamsen, IW
    Somme, S
    Heldal, D
    Egeland, T
    Kvale, D
    Tjonnfjord, GE
    HAEMATOLOGICA, 2005, 90 (01) : 86 - 93
  • [48] Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS
    Laurence M. C. Kok
    Laura Bungener
    Geertruida H. de Bock
    Anouschka Biswana
    Geertiena van der Wal
    Gustaaf W. van Imhoff
    Mar Bellido
    Human Cell, 2020, 33 : 243 - 251
  • [49] Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS
    Kok, Laurence M. C.
    Bungener, Laura
    De Bock, Geertruida H.
    Biswana, Anouschka
    Van der Wal, Geertiena
    Van Imhoff, Gustaaf W.
    Bellido, Mar
    HUMAN CELL, 2020, 33 (01) : 243 - 251
  • [50] High incidence of acute graft-versus-host disease and inflammatory cytokine production with complete rapid donor engraftment after non-myeloablative allogeneic stem cell transplantation.
    Bishop, MR
    Lietzau, J
    Foley, J
    Castro, K
    Kasten-Sportes, C
    Wilson, WH
    Kwak, LW
    Hou, JW
    Marchigiani, D
    Gress, R
    Fowler, DH
    BLOOD, 2000, 96 (11) : 475A - 475A
12345